Vijaya Diagnostic Centre Limited (VIJAYA) Q3 FY23 Earnings Concall Transcript
Categories
Healthcare Services
Apollo Hospitals Enterprise Limited Q3 FY23; Net Profit Down By 33%
Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) reported Revenue from Operations for Q3 FY23 of ₹4,263.58 Crore up from ₹3638.93 Crore year on
Rainbow Children’s Medicare Ltd (RAINBOW) Q3 FY23 Earnings Concall Transcript
Rainbow Children's Medicare Ltd (NSE:RAINBOW) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Ramesh Kancharla -- Chairman and Managing Director R. Gowrisankar -- Chief
Metropolis Healthcare Limited (METROPOLIS) Q3 FY23 Earnings Concall Transcript
Metropolis Healthcare Limited (NSE:METROPOLIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Cyndrella Carvalho -- Vice President - Healthcare/Pharma Lead at JM
Narayana Hrudayalaya Limited (NH) Q3 FY23 Earnings Concall Transcript
Narayana Hrudayalaya Limited (NSE:NH) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Nishant Singh -- Head of Investor Relations Emmanuel Rupert -- Managing
Krishna Institute of Medical Sciences Limited (KIMS) Q3 FY23 Earnings Concall Transcript
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Bhaskar Rao Bollineni -- Founder and Managing
NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript
NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam -- Executive Vice President of Crop Health Science
Healthcare Global Enterprises Ltd (HCG) Q3 FY23 Earnings Concall Transcript
Healthcare Global Enterprises Ltd (NSE:HCG) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: BS Ajai Kumar -- Executive Chairman Raj Gore -- Whole-time Director
Poly Medicure Limited (POLYMED) Q3 FY23 Earnings Concall Transcript
Poly Medicure Limited (NSE:POLYMED) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Himanshu Baid -- Managing Director Analysts: Rohan John -- ICICI Securities --
Mahindra Lifespace Developers Limited (MAHLIFE) Q3 FY23 Earnings Concall Transcript
Mahindra Lifespace Developers Limited (NSE:MAHLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Arvind Subramanian -- Managing Director and Chief Executive Officer
Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY23 Earnings Concall Transcript
Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Anoop Poojari -- Client Manager - Citigate Dewe
Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked about the
Dr. Lal PathLabs Limited Q3 FY23; Net Profit Down By 8%
Dr. Lal PathLabs Limited (NSE: LALPATHLAB) reported a Revenue from Operations of ₹489.4 Crores, a decline of 1.5% from the previous year.
Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Transcript
Laurus Labs Limited (NSE:LAURUSLABS) Q3 FY23 Earnings Concall dated Jan. 30, 2023. Corporate Participants: Satyanarayana Chava -- Founder & Chief Executive Officer V V
VIMTA LABS LTD (VIMTALABS) Q3 FY23 Earnings Concall Transcript
VIMTA LABS LTD (NSE:VIMTALABS) Q3 FY23 Earnings Concall dated Jan. 30, 2023. Corporate Participants: Harita Vasireddi -- Managing Director D.R. Narahai Naidu -- Chief Financial Officer
Jyothy Laboratories Limited (JYOTHYLAB) Q3 FY23 Earnings Concall Transcript
Jyothy Laboratories Limited (NSE:JYOTHYLAB) Q3 FY23 Earnings Concall dated Jan. 25, 2023. Corporate Participants: Sanjay Agarwal -- Chief Financial Officer M R Jyothy -- Managing Director
Solara Active Pharma Sciences Limited (SOLARA) Q3 FY23 Earnings Concall Transcript
Solara Active Pharma Sciences Limited (NSE:SOLARA) Q3 FY23 Earnings Concall dated Jan. 25, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Consultant Jitesh Devendra -- Managing
Apollo Hospitals: Ushering in a New Era
“Our hospital business is on a very strong growth trajectory and will continue to grow. We will improve not only in revenues
Shalby Ltd. Q2FY23; 71% Growth in Profits
Shalby Ltd.‘s revenues in Q2FY23 rose 11% to ₹ 2,018 millions. Consolidated Profit After Tax came at ₹ 184 millions showcasing a
Shalby Limited: A Rising Star?
“With all key strategies in place, our team is extremely committed to flawless execution of these strategies. Shalby is very well poised
MedPlus Health Services Ltd (MEDPLUS) Q2 FY23 Earnings Concall Transcript
MedPlus Health Services Ltd (NSE:MEDPLUS) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Gangadi Madhukar Reddy -- Managing Director and Chief Executive Officer Prasad